These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 12879464)

  • 21. Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes.
    Eisenstein EL; McGuire DK; Bhapkar MV; Kristinsson A; Hochman JS; Kong DF; Califf RM; Van de Werf F; Yancy WS; Newby LK
    Am J Med; 2005 Sep; 118(9):981-90. PubMed ID: 16164884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.
    Sobrero A; Frassineti G; Falcone A; Dogliotti L; Rosso R; Di Costanzo F; Bruzzi P;
    Br J Cancer; 2005 Jan; 92(1):24-9. PubMed ID: 15611795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.
    Navarro WH; Loberiza FR; Bajorunaite R; van Besien K; Vose JM; Lazarus HM; Rizzo JD
    Biol Blood Marrow Transplant; 2006 May; 12(5):541-51. PubMed ID: 16635789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
    J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox.
    Badheka AO; Rathod A; Kizilbash MA; Garg N; Mohamad T; Afonso L; Jacob S
    Am J Med; 2010 Jul; 123(7):646-51. PubMed ID: 20609687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer.
    Schippinger W; Jagoditsch M; Sorré C; Gnant M; Steger G; Hausmaninger H; Mlineritsch B; Schaberl-Moser R; Mischinger HJ; Hofbauer F; Holzberger P; Mittlböck M; Jakesz R;
    Br J Cancer; 2005 May; 92(9):1655-62. PubMed ID: 15856042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The obesity paradox: body mass index and outcomes in patients with heart failure.
    Curtis JP; Selter JG; Wang Y; Rathore SS; Jovin IS; Jadbabaie F; Kosiborod M; Portnay EL; Sokol SI; Bader F; Krumholz HM
    Arch Intern Med; 2005 Jan; 165(1):55-61. PubMed ID: 15642875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I trial of sulindac plus 5-fluorouracil and levamisole: potential adjuvant therapy for colon carcinoma.
    Sinicrope FA; Pazdur R; Levin B
    Clin Cancer Res; 1996 Jan; 2(1):37-41. PubMed ID: 9816087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery.
    Mullen JT; Moorman DW; Davenport DL
    Ann Surg; 2009 Jul; 250(1):166-72. PubMed ID: 19561456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant treatment of node-positive colon carcinoma with levamisole and 5-fluorouracil.
    Grem JL
    Oncology (Williston Park); 1991 Mar; 5(3):63-70, 73; discussion 73-4. PubMed ID: 1829947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
    Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac procedures in patients with a body mass index exceeding 45: outcomes and long-term results.
    Tyson GH; Rodriguez E; Elci OC; Koutlas TC; Chitwood WR; Ferguson TB; Kypson AP
    Ann Thorac Surg; 2007 Jul; 84(1):3-9; discussion 9. PubMed ID: 17588372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
    Meyerhardt JA; Heseltine D; Niedzwiecki D; Hollis D; Saltz LB; Mayer RJ; Thomas J; Nelson H; Whittom R; Hantel A; Schilsky RL; Fuchs CS
    J Clin Oncol; 2006 Aug; 24(22):3535-41. PubMed ID: 16822843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.
    Venturini M; Del Mastro L; Aitini E; Baldini E; Caroti C; Contu A; Testore F; Brema F; Pronzato P; Cavazzini G; Sertoli MR; Canavese G; Rosso R; Bruzzi P
    J Natl Cancer Inst; 2005 Dec; 97(23):1724-33. PubMed ID: 16333028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of body mass index to outcome in patients with known or suspected coronary artery disease.
    Galal W; van Domburg RT; Feringa HH; Schouten O; Elhendy A; Bax JJ; Awara AM; Klein J; Poldermans D
    Am J Cardiol; 2007 Jun; 99(11):1485-90. PubMed ID: 17531566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study.
    Chau GY; Lui WY; Tsay SH; Chao Y; King KL; Wu CW
    Ann Surg Oncol; 2006 Oct; 13(10):1329-37. PubMed ID: 16897271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.